Saturday, February 1, 2025
HomeIndustriesBiotechnology

Biotechnology

TandemAI Announces $25 Million Seed & Pre-series A Financing Led by OrbiMed and Chengwei Capital

TandemAI announced it has raised $25 million in Seed and pre-Series A financing to advance its proprietary computational platform and expansion of its wet...

K2bio Welcomes Ansun BioPharma Biotechnology research accelerator will house Ansun’s Houston based projects.

K2bio has announced Ansun BioPharma, a clinical-stage biopharmaceutical company, together with its wholly-owned subsidiary, Anovac, as an addition to the K2bio community. Ansun's mission...

SkylineDx and VIB enter a strategic partnership in molecular diagnostics

SkylineDx announced a 3-year strategic partnership with life sciences institute VIB for the evaluation and initiation of collaborative projects focused on molecular diagnostics. Under...

Sorriso Pharmaceuticals Launches with $31 Million to Develop Novel Class of Orally Delivered Cytokine Antibodies to Treat Inflammatory Conditions

Sorriso Pharmaceuticals, a company focused on transforming anti-inflammatory antibody therapy, announced the company has closed on a $31 million Series A financing. The round...

Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines

Exopharm Limited has been granted US patent US 11202805 for its LEAP exosome purification technology. This patent positions Exopharm as a global leader in...
0FansLike
0FollowersFollow
spot_img

Hot Topics